Searched for
MOLBIO DIAGNOSTICS Q1 RESULTS
Oracle shares rally: Can strong AI demand sustain Oracle’s stock surge?Oracle shares jumped after the company beat quarterly revenue and earnings estimates, while cloud infrastructure revenue more than doubled ...- AeroVironment shares: Why AVAV fell 5% despite earnings beatAeroVironment reported fiscal Q1 2027 revenue of $480.5 million, up 6% year-on-year, while adjusted earnings beat estimates. Record funded ...
- Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The ...
- Ola Electric shares surge 7%. What’s triggering the sharp uptick in EV major?Ola Electric shares rallied on Thursday as value buying emerged after three consecutive sessions of decline. Around 6.87 crore shares worth...
- DHR Holdings leases 1.8 lakh sq ft in BengaluruDHR Holding India has leased nearly 1.8 lakh square feet of office space in Bengaluru. The company secured three floors at Sumadhura Capito...
- Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocksAt the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies ...
- EBay probes how banned gender-test kits were available in India, listings removedEBay has launched an internal review of its safeguards after Reuters found gender-prediction kits being offered for delivery to India, wher...
- Shiprocket shares gain 3% as Q1 net loss narrows to Rs 14 crore in first earnings post IPO; revenue up 34% YoYShiprocket reported a narrower consolidated net loss of Rs 13.7 crore in Q1FY27, compared with Rs 18 crore a year earlier, while revenue fr...
- Persistent Systems shares fall over 3% as board gives nod for $1.25 billion fundraise. Check detailsPersistent Systems approved plans to raise up to $1.25 billion through debt and up to $450 million via equity-linked instruments, subject t...
- Metal stocks Q1 performance check: 4 beat estimates, 2 missed; Motilal Oswal breaks down the reason
- How 90% IPOs in August beat volatile India market to return up to 72% after listingIn August, a majority of newly listed IPOs saw a successful debut, outpacing the broader market. Approximately ninety percent of these list...
- Demand for vaccines surges as H1N1, other influenza cases see a sharp riseDemand for flu vaccines has significantly increased this year. At-home vaccination services are seeing a substantial rise in bookings. Rapi...
- Corporates urge employees to stay alert as H1N1 cases surgeH1N1 cases have increased significantly, and monsoon fevers are at seasonal highs. Companies are issuing safety guidelines and advising emp...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...
- Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GM...
- Dhoot, Milky Mist or Molbio? What should investors pick in Rs 7,000 crore IPO rush this weekThis week, India's IPO market shines brightly as five firms successfully raise over Rs 7,000 crore. Analysts highlight Dhoot Transmission a...
- Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...
Load More
